Cargando…

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer

AMEERA-1 is a Phase 1/2 open-label single-arm study evaluating once-daily (QD) amcenestrant, an orally bioavailable selective estrogen receptor (ER) degrader, in postmenopausal women with ER+/HER2− advanced breast cancer (NCT03284957), who were mostly heavily pretreated (including targeted therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bardia, Aditya, Chandarlapaty, Sarat, Linden, Hannah M., Ulaner, Gary A., Gosselin, Alice, Cartot-Cotton, Sylvaine, Cohen, Patrick, Doroumian, Séverine, Paux, Gautier, Celanovic, Marina, Pelekanou, Vasiliki, Ming, Jeffrey E., Ternès, Nils, Bouaboula, Monsif, Lee, Joon Sang, Bauchet, Anne-Laure, Campone, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284491/ https://www.ncbi.nlm.nih.gov/pubmed/35840573 http://dx.doi.org/10.1038/s41467-022-31668-8

Ejemplares similares

AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
por: Bardia, Aditya, et al.
Publicado: (2022)

AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer
por: Campone, Mario, et al.
Publicado: (2023)

Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)
por: Tamura, Kenji, et al.
Publicado: (2023)

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2023)

Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader
por: Besret, Laurent, et al.
Publicado: (2020)

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis
por: Moss, Nelson S., et al.
Publicado: (2023)

An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor–Positive Breast Cancer
por: Chandarlapaty, Sarat, et al.
Publicado: (2023)

Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure
por: Osman, Noha, et al.
Publicado: (2022)

Review of hospital effluents: special emphasis on characterization, impact, and treatment of pollutants and antibiotic resistance
por: Fatimazahra, Sayerh, et al.
Publicado: (2023)

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies
por: Rixe, Olivier, et al.
Publicado: (2015)

Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients
por: Ocio, Enrique M., et al.
Publicado: (2023)

Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
por: She, Qing-Bai, et al.
Publicado: (2008)

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
por: Chandarlapaty, Sarat, et al.
Publicado: (2009)

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns
por: Mateo, Lidia, et al.
Publicado: (2020)

Reversible histone glycation is associated with disease-related changes in chromatin architecture
por: Zheng, Qingfei, et al.
Publicado: (2019)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(+), HER2(−) advanced breast cancer: results from BOLERO-2
por: Moynahan, Mary Ellen, et al.
Publicado: (2017)

Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody
por: Lopez-Albaitero, Andres, et al.
Publicado: (2017)

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
por: Fournier, Laure, et al.
Publicado: (2017)

Socio-economic and psychological impact of the COVID-19 outbreak on private practice and public hospital radiologists
por: Florin, Marie, et al.
Publicado: (2020)

The impact of closed versus open kinetic chain exercises on osteoporotic femur neck and risk of fall in postmenopausal women
por: Thabet, Ali Abd El-Monsif, et al.
Publicado: (2017)

Tailoring photonic metamaterial resonances for thermal radiation
por: Bermel, Peter, et al.
Publicado: (2011)

Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on (18)fluorine-fluorodeoxyglucose positron emission tomography/computed tomography
por: Das, Jeeban Paul, et al.
Publicado: (2020)

Effect of pulsed high intensity laser therapy on delayed caesarean section healing in diabetic women
por: Thabet, Ali Abd El-Monsif, et al.
Publicado: (2018)

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
por: Castel, Pau, et al.
Publicado: (2016)

Trends in oncologic hybrid imaging
por: Wibmer, Andreas G., et al.
Publicado: (2018)

KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
por: Gala, Kinisha, et al.
Publicado: (2018)

High-intensity laser therapy versus pulsed electromagnetic field in the treatment of primary dysmenorrhea
por: Thabet, Ali Abd El-Monsif, et al.
Publicado: (2017)

Improved image reconstruction of (89)Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
por: Kirchner, Julian, et al.
Publicado: (2021)

Immigrants facing Covid 19 containment in France : An ordinary hardship of disaffiliation
por: Carillon, Séverine, et al.
Publicado: (2020)

Androgen Receptor Splicing Variant-7 in Breast Cancer: Clinical and Pathologic Correlations
por: Ferguson, Donna C., et al.
Publicado: (2022)

LTC: a novel algorithm to improve the efficiency of contig assembly for physical mapping in complex genomes
por: Frenkel, Zeev, et al.
Publicado: (2010)

UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update
por: Knight, Laura, et al.
Publicado: (2022)

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study
por: Chau, Ian, et al.
Publicado: (2020)

Assessing the Radiological Risks Associated with High Natural Radioactivity of Microgranitic Rocks: A Case Study in a Northeastern Desert of Egypt
por: Abed, Neveen S., et al.
Publicado: (2022)

A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
por: Jhaveri, Komal, et al.
Publicado: (2017)

Correction: LC-MS/MS versus TLC plus GC methods: Consistency of glycerolipid and fatty acid profiles in microalgae and higher plant cells and effect of a nitrogen starvation
por: Jouhet, Juliette, et al.
Publicado: (2018)

LC-MS/MS versus TLC plus GC methods: Consistency of glycerolipid and fatty acid profiles in microalgae and higher plant cells and effect of a nitrogen starvation
por: Jouhet, Juliette, et al.
Publicado: (2017)

Low knowledge of antiretroviral treatments for the prevention of HIV among precarious immigrants from sub-Saharan Africa living in the greater Paris area: Results from the Makasi project
por: Coulibaly, Karna, et al.
Publicado: (2023)

In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2(+) breast cancer
por: Janiszewska, Michalina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v8kdan1bke7h2nv0dda8a1j8lf